Table 3.
The overall results show a stable clinical biomarker signature of mRNA expression across a 90-day test-retesting period with an accuracy of 88% on the retesting data
| Predicted | Visit 2 actual |
Visit 4 actual |
Both actual |
||||||
|---|---|---|---|---|---|---|---|---|---|
| BD | SZ | NC | BD | SZ | NC | BD | SZ | NC | |
| BD | 28 | 1 | 4 | 29 | 1 | 2 | 57 | 2 | 6 |
| SZ | 1 | 26 | 5 | 0 | 28 | 6 | 1 | 54 | 11 |
| NC | 1 | 3 | 21 | 1 | 1 | 22 | 2 | 4 | 43 |
| Accuracy | 83% | 88% | 86% | ||||||
| Sensitivity (SZ) | 87% | 93% | 90% | ||||||
| Sensitivity (BP) | 93% | 97% | 95% | ||||||
| Specificity (NC) | 70% | 73% | 72% | ||||||
BD, bipolar disorder; SZ, schizophrenia; NC, normal control.